Inovio Pharmaceuticals (INO) Revenue & Revenue Breakdown
Inovio Pharmaceuticals Revenue Highlights
Latest Revenue (Y)
$832.01M
Main Segment (Y)
License
Main Geography (Y)
License
Inovio Pharmaceuticals Revenue by Period
Inovio Pharmaceuticals Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $832.01M | 8007.47% |
| 2022-12-31 | $10.26M | 478.23% |
| 2021-12-31 | $1.77M | -76.05% |
| 2020-12-31 | $7.41M | 80.24% |
| 2019-12-31 | $4.11M | -86.51% |
| 2018-12-31 | $30.48M | -27.80% |
| 2017-12-31 | $42.22M | 19.37% |
| 2016-12-31 | $35.37M | -12.83% |
| 2015-12-31 | $40.57M | 288.00% |
| 2014-12-31 | $10.46M | -22.35% |
| 2013-12-31 | $13.47M | 226.98% |
| 2012-12-31 | $4.12M | -57.95% |
| 2011-12-31 | $9.80M | 59.41% |
| 2010-12-31 | $6.14M | -32.62% |
| 2009-12-31 | $9.12M | 334.78% |
| 2008-12-31 | $2.10M | -56.37% |
| 2007-12-31 | $4.81M | 38.62% |
| 2006-12-31 | $3.47M | -36.56% |
| 2005-12-31 | $5.47M | 368.45% |
| 2004-12-31 | $1.17M | 1349.29% |
| 2003-12-31 | $80.53K | -57.51% |
| 2002-12-31 | $189.52K | -95.74% |
| 2001-12-31 | $4.45M | -12.30% |
| 2000-03-31 | $5.08M | -38.83% |
| 1999-03-31 | $8.30M | - |
Inovio Pharmaceuticals generated $832.01M in revenue during NA 2023, up 8007.47% compared to the previous quarter, and up 2729.52% compared to the same period a year ago.
Inovio Pharmaceuticals Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $102.65K | -73.57% |
| 2023-09-30 | $388.45K | 71.90% |
| 2023-06-30 | $225.97K | 96.59% |
| 2023-03-31 | $114.94K | -7.80% |
| 2022-12-31 | $124.67K | -98.64% |
| 2022-09-30 | $9.15M | 1067.03% |
| 2022-06-30 | $784.39K | 294.02% |
| 2022-03-31 | $199.07K | -76.28% |
| 2021-12-31 | $839.12K | 187.67% |
| 2021-09-30 | $291.70K | 6.92% |
| 2021-06-30 | $272.82K | -26.49% |
| 2021-03-31 | $371.12K | -93.35% |
| 2020-12-31 | $5.58M | 2262.87% |
| 2020-09-30 | $236.18K | -11.61% |
| 2020-06-30 | $267.19K | -79.87% |
| 2020-03-31 | $1.33M | 374.89% |
| 2019-12-31 | $279.49K | -67.76% |
| 2019-09-30 | $866.86K | 538.94% |
| 2019-06-30 | $135.67K | -95.21% |
| 2019-03-31 | $2.83M | 13.08% |
| 2018-12-31 | $2.50M | 25.08% |
| 2018-09-30 | $2.00M | -91.82% |
| 2018-06-30 | $24.45M | 1498.33% |
| 2018-03-31 | $1.53M | -82.59% |
| 2017-12-31 | $8.79M | 232.28% |
| 2017-09-30 | $2.64M | -87.04% |
| 2017-06-30 | $20.41M | 96.72% |
| 2017-03-31 | $10.38M | 21.87% |
| 2016-12-31 | $8.51M | -32.11% |
| 2016-09-30 | $12.54M | 102.14% |
| 2016-06-30 | $6.20M | -23.51% |
| 2016-03-31 | $8.11M | 36.64% |
| 2015-12-31 | $5.94M | -75.46% |
| 2015-09-30 | $24.18M | 357.44% |
| 2015-06-30 | $5.29M | 2.32% |
| 2015-03-31 | $5.17M | 110.27% |
| 2014-12-31 | $2.46M | 33.51% |
| 2014-09-30 | $1.84M | -51.59% |
| 2014-06-30 | $3.80M | 61.25% |
| 2014-03-31 | $2.36M | 35.52% |
| 2013-12-31 | $1.74M | -81.66% |
| 2013-09-30 | $9.49M | 1107.58% |
| 2013-06-30 | $785.61K | -46.01% |
| 2013-03-31 | $1.46M | 28.24% |
| 2012-12-31 | $1.13M | 32.77% |
| 2012-09-30 | $854.70K | 95.99% |
| 2012-06-30 | $436.08K | -74.24% |
| 2012-03-31 | $1.69M | 3.70% |
| 2011-12-31 | $1.63M | -38.10% |
| 2011-09-30 | $2.64M | 9.00% |
| 2011-06-30 | $2.42M | -22.08% |
| 2011-03-31 | $3.11M | 31.58% |
| 2010-12-31 | $2.36M | 84.87% |
| 2010-09-30 | $1.28M | 12.48% |
| 2010-06-30 | $1.13M | -17.37% |
| 2010-03-31 | $1.37M | -47.43% |
| 2009-12-31 | $2.61M | -28.35% |
| 2009-09-30 | $3.65M | 46.35% |
| 2009-06-30 | $2.49M | 574.40% |
| 2009-03-31 | $369.45K | 13.03% |
| 2008-12-31 | $326.85K | -28.12% |
| 2008-09-30 | $454.74K | -31.42% |
| 2008-06-30 | $663.03K | 1.53% |
| 2008-03-31 | $653.01K | -80.34% |
| 2007-12-31 | $3.32M | - |
Inovio Pharmaceuticals generated - in revenue during Q1 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Inovio Pharmaceuticals Revenue Breakdown
Inovio Pharmaceuticals Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|
| Other Revenue Affiliated Entity | - | - | - |
| Other Revenue | $627.19K | $786.90K | - |
| License with Affiliated Entities | $245.31K | $1.45M | $235.65K |
| License | $902.26K | $5.17M | $3.64M |
| Grant with Affiliated Revenue | - | - | $1.80K |
| Grant | - | - | $237.54K |
Inovio Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 21: License (50.84%), Other Revenue (35.34%), and License with Affiliated Entities (13.82%).
Quarterly Revenue by Product
| Product/Service | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| License With Affiliated Entities | $7.00K | $6.21K | - | - | - | - | - | - | - | - | - | - | - | - | - |
| License | - | $36.84K | $65.89K | $698.27K | $81.45K | $82.92K | $39.62K | $5.00M | $21.49K | $74.10K | $71.50K | $184.52K | $617.43K | $64.28K | $2.77M |
| Product and Service, Other | - | $741.34K | $124.34K | $115.11K | $115.11K | $281.56K | $111.00K | $97.94K | $83.65K | $39.30K | $196.42K | - | $3.61K | - | - |
| License with Affiliated Entities | - | - | $8.84K | $25.44K | $95.14K | $74.79K | $49.95K | $82.77K | $103.68K | $95.15K | $1.17M | $55.66K | $53.01K | $71.39K | $55.58K |
| Other Revenue Affiliated Entity | - | - | - | - | - | - | - | $494.31K | - | - | - | - | - | - | - |
Inovio Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Sep 22: License With Affiliated Entities (100.00%).
Inovio Pharmaceuticals Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|
| License with Affiliated Entities | $245.31K | $1.45M | $235.65K |
| Other Revenue | $627.19K | $786.90K | - |
| License | $902.26K | $5.17M | $3.64M |
| Other Revenue Affiliated Entity | - | - | - |
| Grant with Affiliated Revenue | - | - | $1.80K |
| Grant | - | - | $237.54K |
Inovio Pharmaceuticals's latest annual revenue breakdown by geography, as of Dec 21: License (50.84%), Other Revenue (35.34%), and License with Affiliated Entities (13.82%).
Quarterly Revenue by Country
| Country | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| License With Affiliated Entities | $7.00K | $6.21K | - | - | - | - | - | - | - | - | - | - | - | - | - |
| License | - | $36.84K | $65.89K | $698.27K | $81.45K | $82.92K | $39.62K | $5.00M | $21.49K | $74.10K | $71.50K | $184.52K | $617.43K | $64.28K | $2.77M |
| Product and Service, Other | - | $741.34K | $124.34K | $115.11K | $115.11K | $281.56K | $111.00K | $97.94K | $83.65K | $39.30K | $196.42K | - | $3.61K | - | - |
| License with Affiliated Entities | - | - | $8.84K | $25.44K | $95.14K | $74.79K | $49.95K | $82.77K | $103.68K | $95.15K | $1.17M | $55.66K | $53.01K | $71.39K | $55.58K |
| Other Revenue Affiliated Entity | - | - | - | - | - | - | - | $494.31K | - | - | - | - | - | - | - |
Inovio Pharmaceuticals's latest quarterly revenue breakdown by geography, as of Sep 22: License With Affiliated Entities (100.00%).
Inovio Pharmaceuticals Peer Comparison by Revenue
INO Revenue FAQ
What is Inovio Pharmaceuticals’s yearly revenue?
Inovio Pharmaceuticals's yearly revenue for 2023 was $832.01M, representing an increase of 8007.47% compared to 2022. The company's yearly revenue for 2022 was $10.26M, representing an increase of 478.23% compared to 2021. INO's yearly revenue for 2021 was $1.77M, representing a decrease of -76.05% compared to 2020.
What is Inovio Pharmaceuticals’s quarterly revenue?
Inovio Pharmaceuticals's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a -100.00% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $102.65K, a -73.57% decrease from the previous quarter (Q3 2023), and a -17.66% decrease year-over-year (Q4 2022). INO's quarterly revenue for Q3 2023 was $388.45K, a 71.90% increase from the previous quarter (Q2 2023), and a -95.76% decrease year-over-year (Q3 2022).
What is Inovio Pharmaceuticals’s revenue growth rate?
Inovio Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 46780.19%, and for the last 5 years (2019-2023) was 20134.05%.
What are Inovio Pharmaceuticals’s revenue streams?
Inovio Pharmaceuticals's revenue streams in c 21 are Other Revenue, License with Affiliated Entities, and License. Other Revenue generated $627.19K in revenue, accounting 35.34% of the company's total revenue, down -20.30% year-over-year. License with Affiliated Entities generated $245.31K in revenue, accounting 13.82% of the company's total revenue, down -83.13% year-over-year. License generated $902.26K in revenue, accounting 50.84% of the company's total revenue, down -82.55% year-over-year.
What is Inovio Pharmaceuticals’s main source of revenue?
For the fiscal year ending Dec 21, the largest source of revenue of Inovio Pharmaceuticals was License. This segment made a revenue of $902.26K, representing 50.84% of the company's total revenue.